Lamotrigine Eg

Lamotrigine, the active ingredient in Lamotrigine Eg, is an anticonvulsant presented as an oral tablet for oral use. It is used to control seizures in epilepsy and to stabilize mood in bipolar disorder, and is prescribed for various seizure types, including partial and generalized tonic‑clonic seizures.

GNH USA supplies Lamotrigine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Lamotrigine is an antiepileptic drug that modulates neuronal excitability in seizure disorders and mood stabilization.

- Epilepsy: Reduces frequency and severity of seizures in patients with focal and generalized epilepsy. - Bipolar disorder: Helps prevent mood episodes, particularly depressive phases, in adults. - Partial seizures: Controls focal onset seizures with or without secondary generalization. - Generalized tonic‑clonic seizures: Decreases occurrence of primary generalized convulsive seizures.

Lamotrigine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: occasional stomach upset. - Rash: mild skin irritation or erythema. - Insomnia: difficulty falling or staying asleep. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Hematologic abnormalities: such as agranulocytosis or aplastic anemia. - Hepatic failure: significant liver enzyme elevation or dysfunction. - Suicidal ideation: emergence of thoughts of self‑harm.

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risks. - Initiate therapy at low dose: start with a minimal dose and titrate gradually. - Monitor skin reactions: discontinue immediately if a rash develops. - Assess hepatic function: evaluate liver enzymes before and during treatment. - Review concomitant medications: avoid drugs that inhibit lamotrigine metabolism. - Counsel on pregnancy: discuss potential risks and benefits with women of child‑bearing potential. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Lamotrigine’s plasma levels can be altered by several co‑administered medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations, risk of toxicity. - Carbamazepine: induces metabolism, substantially lowering lamotrigine levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduce lamotrigine clearance, may require dose increase. - Phenobarbital: enhances lamotrigine metabolism, potentially decreasing efficacy. - Phenytoin: accelerates clearance, may necessitate higher lamotrigine dose. - Serotonergic agents: may increase risk of rash, monitor skin.